$NUWE News

Nuwellis Expands Critical Care Portfolio Through Strategic Commercial Agreement with Atrility Medical

Nuwellis Inc (NUWE) (Q2 2026) Earnings Call Highlights: Revenue Surges 14% and Installed Base ...

Nuwellis, Inc. (NUWE) Q2 2026 Earnings Call Prepared Remarks Transcript

Nuwellis Reports Second Quarter 2026 Financial Results and Business Highlights Focused on Double Digit Revenue Growth and Expanded Gross Margin

Nuwellis Q2 2026 Earnings Call Transcript

Nuwellis Accelerates Digital Transformation of the Aquadex® Platform with EHR Connectivity and Enhanced User Interface

Nuwellis Strengthens Product Development Organization with Appointment of Dale Brady as Principal R&D Engineer

Nuwellis Announces Next-Generation Aquadex Platform Strategy to Expand Future Critical Care Applications

Nuwellis Expanding Capabilities Of Aquadex SmartFlow System Into Broader Extracorporeal Therapy Platform

Nuwellis Announces Pricing of $3.4 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Nuwellis Stock Explodes Thursday: What's Driving the Action?

Nuwellis Announces Acceptance by Frontiers in Pediatrics of New Single-Center Retrospective Study Supporting Alternative Anticoagulation Strategy for Aquadex Ultrafiltration Therapy

Nuwellis Announces Acceptance Of New Single-Center Retrospective Study In Frontiers In Pediatrics Journal

Nuwellis (NUWE) Stock Rallies 90% After Hours: Here's Why it is Trending

Nuwellis Expands Pediatric Footprint with First Aquadex SmartFlow® Installations in Wisconsin

Nuwellis Announces Preliminary Revenue Results for the Second Quarter 2026 Showing Double Digit Growth

Nuwellis’ new CEO on building a strong foundation for sustainable value creation

Nuwellis Announces Preliminary Q2 Earnings With YoY Q2 Revenue Growth Of 14% And H2 Revenue Growth Of 20%

Nuwellis Awarded U.S. Patent for Novel Catheter Technology Designed to Enhance Extracorporeal Therapies

Nuwellis Granted U.S. Patent No. 12678592 B2 For "DUAL LUMEN CATHETER"